Sotera Health’s (SHC) “Outperform” Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Sotera Health (NASDAQ:SHC) in a research note published on Thursday,Benzinga reports. They currently have a $17.00 price target on the stock.

A number of other research firms have also weighed in on SHC. Barclays upped their price objective on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Citigroup increased their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, November 6th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $16.50.

Sotera Health Trading Down 6.1 %

NASDAQ SHC opened at $12.41 on Thursday. The stock has a market cap of $3.52 billion, a PE ratio of 49.64 and a beta of 2.08. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44. The company’s 50-day moving average price is $15.69 and its 200-day moving average price is $13.93. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business’s revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.18 EPS. Equities research analysts forecast that Sotera Health will post 0.61 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the transaction, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. This trade represents a 16.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 55.12% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. CWM LLC increased its holdings in Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after buying an additional 993 shares during the period. True Wealth Design LLC purchased a new position in shares of Sotera Health during the third quarter worth $32,000. GAMMA Investing LLC lifted its position in Sotera Health by 125.0% during the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after purchasing an additional 1,660 shares during the period. Point72 DIFC Ltd grew its position in Sotera Health by 556.6% during the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock worth $78,000 after purchasing an additional 5,544 shares during the period. Finally, Capital Performance Advisors LLP purchased a new position in shares of Sotera Health during the 3rd quarter valued at about $91,000. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.